50% off Premium Yearly

CVE:VHI
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Sales growth has restarted. Margins contracted slightly. Revenues increased by 36% from the same quarter a year prior. They overall missed their quarter but growth prospects still look pretty good. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Competition in the space has increased. The valuation has reached above 6x sales. Valuation is more reasonable at 3x sales. The company also has small cap risk but sales growth has been strong. A 5+ years time horizon. Unlock Premium - Try 5i Free
VitalHub Corp. is a Canadian stock, trading under the symbol VHI.V (previously VHI-X on Stockchase) on the TSX Venture Exchange (VHI-CV). It is usually referred to as TSXV:VHI or VHI.V
In the last year, no analyst issued a Buy, Sell, or Hold rating on VHI.V (previously VHI-X on Stockchase) on Stockchase. Read the latest expert commentary for VitalHub Corp..
VitalHub Corp. was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for VitalHub Corp..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for VitalHub Corp..
VitalHub Corp. is followed by 18 investors on Stockchase and is a trending stock that is worth watching.
On 2021-09-22, VitalHub Corp. (VHI.V) stock closed at a price of $2.98.
2Q sales rose 38% to $13.1M; margins dipped to 81% from 83% due to an increase in lower margin service revenue. EBITDA nearly doubled to $1.9M. Net income was $0.72M from a loss last year. Cash was $22M. Results look good to us; Cormark raised its target price slightly. EPS is predicted to double in 2024, with slower growth following the next year.
Unlock Premium - Try 5i Free